Pernix Therapeutics Holdings, Inc. (PTXT) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
10 NORTH PARK PLACE MORRISTOWN, NJ 07960 |
| State of Incorp. | MD |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2018 MRQ | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 32,820 | 36,375 | 56,135 | 34,855 | 15,647 | 23,023 | |||
| Cash and cash equivalents | 32,820 | 36,375 | 56,135 | 34,855 | 15,647 | 23,023 | |||
| Receivables | 45,440 | 52,143 | 67,944 | 48,850 | 31,086 | 38,293 | |||
| Inventory, net of allowances, customer advances and progress billings | 5,396 | 7,775 | 10,035 | 11,362 | 13,810 | 22,014 | |||
| Inventory | 5,396 | 7,775 | 10,035 | 11,362 | 13,810 | 22,014 | |||
| Prepaid expense | 10,346 | 5,878 | ✕ | ||||||
| Deferred costs | 493 | ||||||||
| Prepaid expense and other current assets | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 3,888 | ||
| Deferred tax assets | 15,933 | 9,301 | 8,118 | ||||||
| Other undisclosed current assets | 10,115 | 12,617 | 23,285 | 7,911 | 664 | (113) | |||
| Total current assets: | 93,771 | 108,910 | 157,399 | 129,257 | 76,385 | 95,715 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 752 | 1,103 | 2,346 | 1,514 | 6,872 | 6,947 | |||
| Long-term investments and receivables | 4,531 | 5,711 | |||||||
| Long-term investments | 5,711 | ||||||||
| Accounts and financing receivable, after allowance for credit loss | 4,531 | ||||||||
| Intangible assets, net (including goodwill), including: | 96,606 | 169,571 | 285,943 | 300,489 | 80,022 | 104,054 | |||
| Goodwill | 12,100 | 30,600 | 54,865 | 44,900 | 42,497 | 37,161 | |||
| Intangible assets, net (excluding goodwill) | 182,212 | 328,142 | 545,386 | 552,278 | 54,322 | 58,216 | |||
| Other undisclosed intangible assets, net (including goodwill) | (97,706) | (189,171) | (314,308) | (296,689) | (16,797) | 8,678 | |||
| Other noncurrent assets | 2,263 | 257 | 10,605 | 11,253 | 1,079 | ✕ | |||
| Prepaid expense and other noncurrent assets | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 1,859 | ||
| Deferred tax assets, net | (202) | (9,389) | (15,499) | (35,536) | |||||
| Other undisclosed noncurrent assets | 12,100 | 30,600 | 55,067 | 54,289 | 57,996 | 72,696 | |||
| Total noncurrent assets: | 111,721 | 201,531 | 353,759 | 358,156 | 135,001 | 155,731 | |||
| TOTAL ASSETS: | 205,492 | 310,441 | 511,158 | 487,413 | 211,386 | 251,447 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 80,580 | 23,529 | 30,320 | 19,131 | 7,247 | 7,927 | |||
| Interest and dividends payable | 10,612 | 10,897 | 11,903 | 10,159 | |||||
| Employee-related liabilities | 5,748 | ||||||||
| Accounts payable | 7,911 | 7,275 | 14,081 | 5,399 | 3,444 | 5,045 | |||
| Accrued liabilities | 56,309 | 5,357 | 4,336 | 3,573 | 3,803 | 2,882 | |||
| Debt | 3,664 | 11,103 | 15,044 | 14,690 | 33,999 | 2,287 | |||
| Other liabilities | 2,648 | 5,224 | 10,002 | 3,264 | 4,073 | ||||
| Other undisclosed current liabilities | 6,909 | 69,672 | 78,786 | 60,592 | 24,148 | 43,733 | |||
| Total current liabilities: | 93,801 | 109,528 | 134,152 | 97,677 | 69,468 | 53,947 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation, including: | 279,976 | 290,321 | 313,749 | 292,345 | 18,309 | ||||
| Long-term debt, excluding current maturities | 279,976 | 290,321 | 313,749 | 65,000 | |||||
| Other undisclosed long-term debt and lease obligation | 227,345 | 18,309 | |||||||
| Liabilities, other than long-term debt | 5,972 | 24,655 | 29,958 | 11,755 | 14,388 | ||||
| Estimated litigation liability | 2,000 | 17,522 | |||||||
| Other liabilities | 2,521 | 4,500 | 6,738 | 11,755 | 14,388 | ||||
| Business combination, contingent consideration, liability | 1,358 | 2,403 | 14,055 | ✕ | ✕ | ||||
| Derivative instruments and hedges, liabilities | 93 | 230 | 9,165 | ||||||
| Other undisclosed noncurrent liabilities | 202 | 2,044 | (1,501) | 84,651 | |||||
| Total noncurrent liabilities: | 285,948 | 314,976 | 343,909 | 306,144 | 31,197 | 84,651 | |||
| Total liabilities: | 379,749 | 424,504 | 478,061 | 403,821 | 100,664 | 138,598 | |||
| Temporary equity, carrying amount | 34,310 | ||||||||
| Equity | |||||||||
| Equity, attributable to parent | (174,257) | (114,063) | 33,097 | 83,592 | 110,722 | 78,539 | |||
| Common stock | 119 | 100 | 611 | 383 | 372 | 296 | |||
| Treasury stock, value | (5,548) | (5,431) | (4,001) | (3,772) | |||||
| Additional paid in capital | 261,158 | 244,309 | 226,837 | 129,128 | 119,554 | 58,607 | |||
| Accumulated other comprehensive income (loss) | (79) | 2,975 | |||||||
| Retained earnings (accumulated deficit) | (435,534) | (358,393) | (188,803) | (40,488) | (5,202) | 20,433 | |||
| Total equity: | (174,257) | (114,063) | 33,097 | 83,592 | 110,722 | 78,539 | |||
| TOTAL LIABILITIES AND EQUITY: | 205,492 | 310,441 | 511,158 | 487,413 | 211,386 | 251,447 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2018 TTM | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 146,068 | 140,856 | 175,850 | 121,747 | 84,872 | 61,313 | ||
| Revenue, net | ✕ | 118 | 115 | 19 | 121,747 | 84,872 | 61,313 | |
| Cost of revenue | (46,606) | (43,320) | (51,408) | (2,600) | (6,359) | (24,575) | ||
| Cost of goods and services sold | (44,631) | (43,320) | (51,408) | (46,356) | (45,156) | (24,575) | ||
| Gross profit: | 99,462 | 97,536 | 124,442 | 119,147 | 78,513 | 36,737 | ||
| Operating expenses | (155,921) | (237,864) | (225,696) | (105,972) | (95,662) | (39,360) | ||
| Other undisclosed operating income (loss) | (43,389) | (37,512) | 933 | |||||
| Operating loss: | (56,459) | (140,328) | (101,254) | (30,214) | (54,661) | (1,689) | ||
| Nonoperating income (expense) (Other Nonoperating Income (Expense)) | (20,309) | (28,823) | (39,999) | (18,797) | 8,269 | |||
| Interest and debt expense | (3,296) | (2,440) | (1,618) | (2,333) | ||||
| Loss from continuing operations before equity method investments, income taxes: | (80,064) | (171,591) | (142,871) | (51,344) | (46,391) | (1,689) | ||
| Other undisclosed income from continuing operations before income taxes | 3,296 | 2,440 | 1,618 | 2,333 | ||||
| Loss from continuing operations before income taxes: | (76,768) | (169,151) | (141,253) | (49,011) | (46,391) | (1,689) | ||
| Income tax expense (benefit) | (373) | (439) | (7,062) | 13,725 | 20,756 | 374 | ||
| Loss from continuing operations: | (77,141) | (169,590) | (148,315) | (35,286) | (25,635) | (1,315) | ||
| Loss before gain (loss) on sale of properties: | (77,141) | (169,590) | (148,315) | (35,286) | (25,635) | (1,315) | ||
| Net loss: | (77,141) | (169,590) | (148,315) | (35,286) | (25,635) | (1,315) | ||
| Other undisclosed net loss attributable to parent | (95) | |||||||
| Net loss available to common stockholders, diluted: | (77,141) | (169,590) | (148,315) | (35,286) | (25,635) | (1,410) | ||
Comprehensive Income ($ in thousands)
| 9/30/2018 TTM | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (77,141) | (169,590) | (148,315) | (35,286) | (25,635) | (1,315) | ||
| Other comprehensive income (loss) | 79 | (79) | ||||||
| Comprehensive loss: | (77,062) | (169,669) | (148,315) | (35,286) | (25,635) | (1,315) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (2,975) | 1,791 | ||||||
| Comprehensive income (loss), net of tax, attributable to parent: | (77,062) | (169,669) | (148,315) | (35,286) | (28,610) | 476 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.